BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 21503902)

  • 1. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
    Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
    J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
    Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
    Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult HCV and occult HBV coinfection in Iranian human immunodeficiency virus-infected individuals.
    Jamshidi S; Bokharaei-Salim F; Esghaei M; Bastani MN; Garshasbi S; Chavoshpour S; Dehghani-Dehej F; Fakhim S; Khanaliha K
    J Med Virol; 2020 Dec; 92(12):3354-3364. PubMed ID: 32232978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.
    Reuter S; Oette M; Wilhelm FC; Beggel B; Kaiser R; Balduin M; Schweitzer F; Verheyen J; Adams O; Lengauer T; Fätkenheuer G; Pfister H; Häussinger D
    Med Microbiol Immunol; 2011 Feb; 200(1):39-49. PubMed ID: 20853118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.
    Rusine J; Ondoa P; Asiimwe-Kateera B; Boer KR; Uwimana JM; Mukabayire O; Zaaijer H; Mugabekazi J; Reiss P; van de Wijgert JH
    PLoS One; 2013; 8(5):e63303. PubMed ID: 23717409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
    Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
    Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.
    Morsica G; Ancarani F; Bagaglio S; Maracci M; Cicconi P; Cozzi Lepri A; Antonucci G; Bruno R; Santantonio T; Tacconi L; Baldelli F; Piscopo R; Santoro D; Lazzarin A; D'Arminio Monforte A;
    Infection; 2009 Oct; 37(5):445-9. PubMed ID: 19669092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela.
    Blanco RY; Loureiro CL; Villalba JA; Sulbarán YF; Maes M; de Waard JH; Rangel HR; Jaspe RC; Pujol FH
    PLoS One; 2018; 13(5):e0197662. PubMed ID: 29799873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia.
    Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y
    Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR; Gui X; Chen XY; Zhu Y
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
    Lo Re V; Frank I; Gross R; Dockter J; Linnen JM; Giachetti C; Tebas P; Stern J; Synnestvedt M; Localio AR; Kostman JR; Strom BL
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):315-20. PubMed ID: 17159655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.